Point of Care Molecular Diagnostics Market Size By Technology [Polymerase Chain Reaction (Real Time PCR, DNA/RNA Purification), In Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others], By Infectious Diseases (MRSA, Clostridium Difficile, Vancomycin-resistant Enterococci, Carbapenem-Resistant Bacteria Testing, Flu, Respiratory Syncytial Virus, Candida, Tuberculosis and Drug-resistant TB, Meningitis, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HIV , Hepatitis C, Hepatitis B, HPV, Syphilis,), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, South Korea, Malaysia, Thailand, Vietnam, Philippines, Australia, Brazil, Argentina, Mexico, South Africa, Nigeria, Egypt, Morocco, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Point of Care Molecular Diagnostics Market will exceed USD 2.5 billion by 2025; as per a new research report.

Technological advancements in point of care molecular diagnostic tests will surge industry growth in the coming years. Recently introduced tests have rapid turn around time and provide maximum comfort to patients. Moreover, technology integrated in these PoC molecular tests reduce the reliance on presumptive treatment as well as minimizes need for multiple patient visits. Furthermore, now-a-days, most of the PoC rapid diagnostic tests use versatile platform that enhances their preference. Above mentioned factors should positively impact the point of care molecular diagnostics market growth.

Rising incidences of infectious diseases should augment the demand for PoC molecular diagnostic tests. According to CDC, in 2016, incidence of salmonella infections and Lyme diseases was 53,850 and 36,429 respectively in the U.S. alone. Similarly, in developing and underdeveloped economies the incidence of infectious diseases is continuously increasing. This scenario proves beneficial for the industry growth as it increases the demand for efficient PoC molecular diagnostic tests. However, stringent regulatory scenario may affect the industry growth to some extent.

Chips and microarrays segment is expected to witness around 7% growth in the coming years. This technology has seamless applications and has been highly adopted in recent times. It integrates one or several laboratory functions and provides high-throughput screening. Moreover, automation introduced in the microarrays have enabled the healthcare professionals to obtain accurate analysis that will boost their preference stimulating the segmental growth in the coming years.

Flu segment was valued more than USD 150 million in 2018. India and other emerging countries have significant percentage of population suffering from flu. Developing and underdeveloped countries have hygiene issues that makes the population susceptible to flu that spurs the demand for PoC tests. Additionally, rising awareness regarding availability of advanced rapid diagnostic tests for influenza and other infections will further escalate the business growth.

North America point of care molecular diagnostic market held over 41% revenue share in 2018. Considerable regional growth can be attributed to the favorable demographic trends. Increasing geriatric population susceptible to several chronic infections will propel the demand for PoC molecular tests. Furthermore, favorable regulatory scenario for PoC molecular diagnostic tests should elevate the regional growth in the coming years.

Some of the players operating in the PoC molecular diagnostics market are Abaxis, Roche, Abbott, Danaher, BioMerieux, Sysmex, Bio-Rad Laboratories, OraSure Technologies and Bayer. These industry players adopt certain strategic initiatives such as product launches, mergers and acquisitions for maintaining their market position. For instance, in July 2017, Roche launched first fully automated CE marked cobas 6800/8800 Systems for HIV-1/HIV-2 qualitative diagnostic test. Test offers healthcare specialists to distinguish HIV-1 from HIV-2, that enable providers to enhance treatment options on the basis of infections. Launch of new product will broaden Roche?s product portfolio.
Report Content
 
 Chapter 1. Methodology
 
 1.1. Methodology
 
 1.2. Market definitions
 
 1.3. Forecast parameters
 
 1.4. Data sources
 
 1.4.1. Secondary
 
 1.4.1.1. Paid sources
 
 1.4.1.2. Unpaid sources
 
 1.4.2. Primary
 
 Chapter 2. Executive Summary
 
 2.1. Point-of-Care (PoC) molecular diagnostics industry 360 degree synopsis, 2014 - 2025
 
 2.1.1. Business trends
 
 2.1.2. Technology trends
 
 2.1.3. Infectious disease trends
 
 2.1.4. Regional trends
 
 Chapter 3. Point-of-Care (PoC) Molecular Diagnostics Industry Insights
 
 3.1. Industry segmentation
 
 3.2. Industry landscape, 2014 - 2025
 
 3.3. Industry impact forces
 
 3.3.1. Growth drivers
 
 3.3.1.1. Increasing incidences of infectious diseases
 
 3.3.1.2. Growing awareness about pre-disease diagnostics to control occurrence of diseases
 
 3.3.1.3. Technological advancements in DNA sequencing and analysis
 
 3.3.1.4. Increasing R&D activities in drug discovery
 
 3.3.2. Industry pitfalls & challenges
 
 3.3.2.1. Long product development time
 
 3.3.2.2. Complex regulatory process
 
 3.4. Growth potential analysis
 
 3.4.1. By technology
 
 3.4.2. By infectious disease
 
 3.5. Technology landscape
 
 3.6. All in one diagnostics solutions overview
 
 3.7. Porter's analysis
 
 3.8. Competitive landscape, 2018
 
 3.8.1. Strategy dashboard
 
 3.9. PESTEL analysis
 
 Chapter 4. Point-of-Care (PoC) Molecular Diagnostics Market, By Technology
 
 4.1. Key trends
 
 4.2. PCR (Polymerase Chain Reaction)
 
 4.2.1. Market size, by region, 2014 - 2025, (USD Million)
 
 4.2.2. Real time PCR
 
 4.2.2.1. Market size, by region, 2014 - 2025, (USD Million)
 
 4.2.3. DNA/RNA purification
 
 4.2.3.1. Market size, by region, 2014 - 2025, (USD Million)
 
 4.3. In Situ Hybridization
 
 4.3.1. Market size, by region, 2014 - 2025, (USD Million)
 
 4.4. Chips and microarrays
 
 4.4.1. Market size, by region, 2014 - 2025, (USD Million)
 
 4.5. Mass spectrometry
 
 4.5.1. Market size, by region, 2014 - 2025, (USD Million)
 
 4.6. Sequencing
 
 4.6.1. Market size, by region, 2014 - 2025, (USD Million)
 
 4.7. Isothermal amplification
 
 4.7.1. Market size, by region, 2014 - 2025, (USD Million)
 
 Chapter 5. Point-of-Care (PoC) Molecular Diagnostics Market, By Infectious Disease
 
 5.1. Point-of-Care (PoC) molecular diagnostics market share by infectious disease, 2018 & 2025
 
 5.2. MRSA
 
 5.2.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.3. Clostridium difficile
 
 5.3.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.4. Vancomycin-resistant enterococci
 
 5.4.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.5. Carbapenem-resistant bacteria testing
 
 5.5.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.6. Flu
 
 5.6.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.7. Respiratory syncytial virus (RSV)
 
 5.7.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.8. Candida
 
 5.8.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.9. Tuberculosis and drug-resistant TB
 
 5.9.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.10. Meningitis
 
 5.10.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.11. Gastro-intestinal panel testing
 
 5.11.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.12. Chlamydia
 
 5.12.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.13. Gonorrhea
 
 5.13.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.14. HIV
 
 5.14.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.15. Hepatitis C
 
 5.15.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.16. Hepatitis B
 
 5.16.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.17. HPV
 
 5.17.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.18. Syphilis
 
 5.18.1. Market size, by region, 2014 - 2025, (USD Million)
 
 5.19. Others
 
 5.19.1. Market size, by region, 2014 - 2025, (USD Million)
 
 Chapter 6. Point-of-Care (PoC) Molecular Diagnostics Market, By Region
 
 6.1. Key segment trends
 
 6.2. North America
 
 6.2.1. Market size, by country, 2014 - 2025, (USD Million)
 
 6.2.2. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.2.3. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.2.4. U.S.
 
 6.2.4.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.2.4.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.2.5. Canada
 
 6.2.5.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.2.5.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.3. Europe
 
 6.3.1. Market size, by country, 2014 - 2025, (USD Million)
 
 6.3.2. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.3.3. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.3.4. Germany
 
 6.3.4.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.3.4.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.3.5. UK
 
 6.3.5.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.3.5.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.3.6. France
 
 6.3.6.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.3.6.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.3.7. Italy
 
 6.3.7.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.3.7.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.3.8. Spain
 
 6.3.8.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.3.8.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.3.9. Russia
 
 6.3.9.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.3.9.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4. Asia Pacific
 
 6.4.1. Market size, by country, 2014 - 2025, (USD Million)
 
 6.4.2. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.3. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.4. Japan
 
 6.4.4.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.4.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.5. China
 
 6.4.5.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.5.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.6. India
 
 6.4.6.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.6.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.7. South Korea
 
 6.4.7.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.7.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.8. Malaysia
 
 6.4.8.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.8.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.9. Thailand
 
 6.4.9.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.9.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.10. Vietnam
 
 6.4.10.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.10.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.11. Philippines
 
 6.4.11.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.11.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.4.12. Australia
 
 6.4.12.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.4.12.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.5. Latin America
 
 6.5.1. Market size, by country, 2014 - 2025, (USD Million)
 
 6.5.2. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.5.3. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.5.4. Brazil
 
 6.5.4.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.5.4.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.5.5. Mexico
 
 6.5.5.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.5.5.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.5.6. Argentina
 
 6.5.6.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.5.6.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.6. Middle East & Africa
 
 6.6.1. Market size, by country, 2014 - 2025, (USD Million)
 
 6.6.2. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.6.3. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.6.4. South Africa
 
 6.6.4.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.6.4.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.6.5. Nigeria
 
 6.6.5.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.6.5.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.6.6. Egypt
 
 6.6.6.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.6.6.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.6.7. Morocco
 
 6.6.7.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.6.7.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.6.8. Saudi Arabia
 
 6.6.8.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.6.8.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 6.6.9. UAE
 
 6.6.9.1. Market size, by technology, 2014 - 2025, (USD Million)
 
 6.6.9.2. Market size, by infectious disease, 2014 - 2025, (USD Million)
 
 Chapter 7. Company Profiles
 
 7.1. Abaxis Inc.
 
 7.1.1. Business overview
 
 7.1.2. Financial data
 
 7.1.3. Product landscape
 
 7.1.4. Strategic outlook
 
 7.1.5. SWOT analysis
 
 7.2. Abbott Laboratories
 
 7.2.1. Business overview
 
 7.2.2. Financial data
 
 7.2.3. Product landscape
 
 7.2.4. Strategic outlook
 
 7.2.5. SWOT analysis
 
 7.3. Bayer Corporation
 
 7.3.1. Business overview
 
 7.3.2. Financial data
 
 7.3.3. Product landscape
 
 7.3.4. Strategic outlook
 
 7.3.5. SWOT analysis
 
 7.4. bioMerieux SA
 
 7.4.1. Business overview
 
 7.4.2. Financial data
 
 7.4.3. Product landscape
 
 7.4.4. Strategic outlook
 
 7.4.5. SWOT analysis
 
 7.5. Bio-rad Laboratories
 
 7.5.1. Business overview
 
 7.5.2. Financial data
 
 7.5.3. Product landscape
 
 7.5.4. Strategic outlook
 
 7.5.5. SWOT analysis
 
 7.6. Danaher Corporation
 
 7.6.1. Business overview
 
 7.6.2. Financial data
 
 7.6.3. Product landscape
 
 7.6.4. Strategic outlook
 
 7.6.5. SWOT analysis
 
 7.7. OraSure Technologies Inc.
 
 7.7.1. Business overview
 
 7.7.2. Financial data
 
 7.7.3. Product landscape
 
 7.7.4. Strategic outlook
 
 7.7.5. SWOT analysis
 
 7.8. Roche Diagnostics
 
 7.8.1. Business overview
 
 7.8.2. Financial data
 
 7.8.3. Product landscape
 
 7.8.4. Strategic outlook
 
 7.8.5. SWOT analysis
 
 7.9. Sysmex Corporation
 
 7.9.1. Business overview
 
 7.9.2. Financial data
 
 7.9.3. Product landscape
 
 7.9.4. Strategic outlook
 
 7.10. Vircell Microbiologists
 
 7.10.1. Business overview
 
 7.10.2. Financial data
 
 7.10.3. Product landscape
 
 7.10.4. Strategic outlook

Data Tables TABLE 1. PoC molecular diagnostics industry 360 degree synopsis, 2014 - 2025 TABLE 2. PoC molecular diagnostics market, 2014 - 2025 (USD Million) TABLE 3. PoC molecular diagnostics market, by technology, 2014 - 2025 (USD Million) TABLE 4. PoC molecular diagnostics market, by infectious disease, 2014 - 2025 (USD Mn) TABLE 5. PoC molecular diagnostics market, by region, 2014 - 2025 (USD Million) TABLE 6. Industry impact forces TABLE 7. PCR (Polymerase Chain Reaction) market size, by region, 2014 - 2025 (USD Million) TABLE 8. Real time PCR market size, by region, 2014 - 2025 (USD Million) TABLE 9. DNA/RNA purification market size, by region, 2014 - 2025 (USD Million) TABLE 10. In situ hybridization market size, by region, 2014 - 2025 (USD Million) TABLE 11. Chips and microarrays market size, by region, 2014 - 2025 (USD Million) TABLE 12. Mass spectrometry market size, by region, 2014 - 2025 (USD Million) TABLE 13. Sequencing market size, by region, 2014 - 2025 (USD Million) TABLE 14. Isothermal amplification market size, by region, 2014 - 2025 (USD Million) TABLE 15. MRSA market size, by region, 2014 - 2025 (USD Million) TABLE 16. Clostridium difficile market size, by region, 2014 - 2025 (USD Million) TABLE 17. Vancomycin-resistant enterococci market size, by region, 2014 - 2025 (USD Million) TABLE 18. Carbapenem-resistant bacteria testing market size, by region, 2014 - 2025 (USD Mn) TABLE 19. Flu market size, by region, 2014 - 2025 (USD Million) TABLE 20. Respiratory syncytial virus (RSV) market size, by region, 2014 - 2025 (USD Million) TABLE 21. Candida market size, by region, 2014 - 2025 (USD Million) TABLE 22. Tuberculosis and drug-resistant TB market size, by region, 2014 - 2025 (USD Million) TABLE 23. Meningitis market size, by region, 2014 - 2025 (USD Million) TABLE 24. Gastro-intestinal panel testing market size, by region, 2014 - 2025 (USD Million) TABLE 25. Chlamydia market size, by region, 2014 - 2025 (USD Million) TABLE 26. Gonorrhea market size, by region, 2014 - 2025 (USD Million) TABLE 27. HIV market size, by region, 2014 - 2025 (USD Million) TABLE 28. Hepatitis C market size, by region, 2014 - 2025 (USD Million) TABLE 29. Hepatitis B market size, by region, 2014 - 2025 (USD Million) TABLE 30. HPV market size, by region, 2014 - 2025 (USD Million) TABLE 31. Syphilis market size, by region, 2014 - 2025 (USD Million) TABLE 32. Others market size, by region, 2014 - 2025 (USD Million) TABLE 33. North America market size, by country, 2014 - 2025 (USD Million) TABLE 34. North America market size, by technology, 2014 - 2025 (USD Million) TABLE 35. North America market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 36. North America market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 37. U.S. market size, by technology, 2014 - 2025 (USD Million) TABLE 38. U.S. market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 39. U.S. market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 40. Canada market size, by technology, 2014 - 2025 (USD Million) TABLE 41. Canada market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 42. Canada market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 43. Europe market size, by country, 2014 - 2025 (USD Million) TABLE 44. Europe market size, by technology, 2014 - 2025 (USD Million) TABLE 45. Europe market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 46. Europe market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 47. Germany market size, by technology, 2014 - 2025 (USD Million) TABLE 48. Germany market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 49. Germany market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 50. UK market size, by technology, 2014 - 2025 (USD Million) TABLE 51. UK market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 52. UK market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 53. France market size, by technology, 2014 - 2025 (USD Million) TABLE 54. France market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 55. France market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 56. Spain market size, by technology, 2014 - 2025 (USD Million) TABLE 57. Spain market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 58. Spain market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 59. Italy market size, by technology, 2014 - 2025 (USD Million) TABLE 60. Italy market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 61. Italy market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 62. Russia market size, by technology, 2014 - 2025 (USD Million) TABLE 63. Russia market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 64. Russia market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 65. Asia Pacific market size, by country, 2014 - 2025 (USD Million) TABLE 66. Asia Pacific market size, by technology, 2014 - 2025 (USD Million) TABLE 67. Asia Pacific market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 68. Asia Pacific market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 69. Japan market size, by technology, 2014 - 2025 (USD Million) TABLE 70. Japan market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 71. Japan market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 72. China market size, by technology, 2014 - 2025 (USD Million) TABLE 73. China market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 74. China market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 75. India market size, by technology, 2014 - 2025 (USD Million) TABLE 76. India market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 77. India market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 78. South Korea market size, by technology, 2014 - 2025 (USD Million) TABLE 79. South Korea market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 80. South Korea market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 81. Malaysia market size, by technology, 2014 - 2025 (USD Million) TABLE 82. Malaysia market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 83. Malaysia market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 84. Thailand market size, by technology, 2014 - 2025 (USD Million) TABLE 85. Thailand market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 86. Thailand market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 87. Vietnam market size, by technology, 2014 - 2025 (USD Million) TABLE 88. Vietnam market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 89. Vietnam market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 90. Philippines market size, by technology, 2014 - 2025 (USD Million) TABLE 91. Philippines market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 92. Philippines market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 93. Australia market size, by technology, 2014 - 2025 (USD Million) TABLE 94. Australia market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 95. Australia market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 96. Latin America market size, by country, 2014 - 2025 (USD Million) TABLE 97. Latin America market size, by technology, 2014 - 2025 (USD Million) TABLE 98. Latin America market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 99. Latin America market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 100. Brazil market size, by technology, 2014 - 2025 (USD Million) TABLE 101. Brazil market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 102. Brazil market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 103. Argentina market size, by technology, 2014 - 2025 (USD Million) TABLE 104. Argentina market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 105. Argentina market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 106. Mexico market size, by technology, 2014 - 2025 (USD Million) TABLE 107. Mexico market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 108. Mexico market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 109. MEA market size, by country, 2014 - 2025 (USD Million) TABLE 110. MEA market size, by technology, 2014 - 2025 (USD Million) TABLE 111. MEA market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 112. MEA market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 113. South Africa market size, by technology, 2014 - 2025 (USD Million) TABLE 114. South Africa market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 115. South Africa market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 116. Nigeria market size, by technology, 2014 - 2025 (USD Million) TABLE 117. Nigeria market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 118. Nigeria market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 119. Egypt market size, by technology, 2014 - 2025 (USD Million) TABLE 120. Egypt market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 121. Egypt market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 122. Morocco market size, by technology, 2014 - 2025 (USD Million) TABLE 123. Morocco market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 124. Morocco market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 125. Saudi Arabia market size, by technology, 2014 - 2025 (USD Million) TABLE 126. Saudi Arabia market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 127. Saudi Arabia market size, by infectious disease, 2014 - 2025 (USD Million) TABLE 128. UAE market size, by technology, 2014 - 2025 (USD Million) TABLE 129. UAE market size, by PCR technology, 2014 - 2025 (USD Million) TABLE 130. UAE market size, by infectious disease, 2014 - 2025 (USD Million) Charts & Figures FIG 1. Reported cases of acute hepatitis in the U.S., (2012-2016) FIG 2. Industry segmentation FIG 3. Global PoC molecular diagnostics market, 2014 - 2025 (USD Million) FIG 4. Stages of new invitro diagnostic product development FIG 5. Growth potential analysis, by technology FIG 6. Growth potential analysis, by infectious diseases FIG 7. Potential addressable end users of all in one diagnostic solutions FIG 8. Comparison of time taken in standard processing and all-in-one FIG 9. All in one diagnostic, industry drivers and pitfalls FIG 10. Porter's analysis FIG 11. Strategy dashboard FIG 12 PESTEL analysis

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by Global Market Insights, Inc.

U.S. Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

U.S. Direct-To-Consumer Genetic Testing Market is expected to exceed USD 850 million by 2025. Increasing public awareness pertaining to availability of DTC genetic testing kits will be a high impact rendering factor for the U.S. DTC genetic testing m...

New Pharmaceuticals and Healthcare Reports

Publisher: Global Market Insights, Inc. 150 Pages